VACCINE FOR NEUROCYSTICERCOSIS: A PRESENT UPDATE
Keywords:
Neurocysticercosis, vaccine, infectionAbstract
Cysticercosis is an important tropical parasitic worm infestation. This infection can result in cyst in any organs of human beings including to brain. The brain involvement of cysticercosis or neurocyticercosis is an important neurological infection that can cause serious neuruological problem. A good sanitation is the basic prevention for cysticercosis. Nevertheless, the hope is the use of vaccination. Here, the author briefly reviews and discusses on the present situation of neurocysticercosis vaccine.
References
Pawlowski Z, Schultz MG. Taeniasis and cysticercosis (Taenia saginata). Adv Parasitol. 1972;10:269-343.
Mewara A, Goyal K, Sehgal R. Neurocysticercosis: A disease of neglect. Trop Parasitol. 2013 Jul;3(2):106-13.
Joob B, Wiwanitkit V. Neurocysticercosis. Arq Neuropsiquiatr. 2014 Mar;72(3):260.
Pawlowski ZS. Control of neurocysticercosis by routine medical and veterinary services. Trans R Soc Trop Med Hyg. 2008 Mar;102(3):228-32.
Zimic M, Gutiérrez AH, Gilman RH, López C, Quiliano M, Evangelista W, Gonzales A, GarcÃa HH, Sheen P. Immunoinformatics prediction of linear epitopes from Taenia solium TSOL18. Bioinformation. 2011;6(7):271-4.
Mapping of Taenia solium TSOL18 antigenic epitopes by phage display library. Guo A1, Cai X, Jia W, Liu B, Zhang S, Wang P, Yan H, Luo X. Parasitol Res. 2010 Apr;106(5):1151-7.
Kyngdon CT, Gauci CG, Gonzalez AE, Flisser A, Zoli A, Read AJ, MartÃnez-Ocaña J, Strugnell RA, Lightowlers MW. Antibody responses and epitope specificities to the Taenia solium cysticercosis vaccines TSOL18 and TSOL45-1A. Parasite Immunol. 2006 May;28(5):191-9.
Lightowlers MW. Control of Taenia solium taeniasis/cysticercosis: past practices and new possibilities. Parasitology. 2013 Nov;140(13):1566-77.
DÃaz-Orea MA, Mijares JM, Arcega R, GómezConde E, Castellanos-Sánchez VO, BrionesRojas R, Flores-Alonso JC, MarÃn-Briones MÃ, Santos-López G. In vitro effect of the S3Pvac vaccine against cysticercosis in human mononucleate cells]. [Article in Spanish; Abstract available in Spanish from the publisher. Rev Neurol. 2013 May 1;56(9):45663.
Sciutto E, Fragoso G, Hernández M, Rosas G, MartÃnez JJ, Fleury A, Cervantes J, Aluja A, Larralde C. Development of the S3Pvac vaccine against porcine Taenia solium cysticercosis: a historical reviewJ Parasitol. 2013 Aug;99(4):686-92.
De Aluja AS, Herrera GS, Hernández M, Plancarte A, Fragoso G, Sciutto E. Limits of the therapeutic properties of synthetic S3Pvac anti-cysticercosis vaccine. Vet Parasitol. 2011 Apr 19;177(1-2):90-6.
Gauci C, Jayashi C, Lightowlers MW. Vaccine development against the Taenia solium parasite: the role of recombinant protein expression in Escherichia coli. Bioengineered. 2013 Sep-Oct;4(5):343-7.
Ding J, Zheng Y, Wang Y, Dou Y, Chen X, Zhu X, Wang S, Zhang S, Liu Z, Hou J, Zhai J, Yan H, Luo X, Cai X. Immune responses to a recombinant attenuated Salmonella typhimurium strain expressing a Taenia solium oncosphere antigen TSOL18. Comp Immunol Microbiol Infect Dis. 2013 Jan;36(1):17-23.
Monreal-Escalante E, Bañuelos-Hernández B, Hernández M, Fragoso G, Garate T, Sciutto E, Rosales-Mendoza S. Expression of Multiple Taenia Solium Immunogens in Plant Cells Through a Ribosomal Skip Mechanism. Mol Biotechnol. 2015 Jul;57(7):635-43.
